Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $1.63B.
ENTERPRISE VALUE (EV)
$1.63B
Intellia Therapeutics, Inc.
Market Cap
$1.72B
Enterprise Value (EV)
$1.63B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Intellia Therapeutics, Inc. (NTLA) | $1.72B | $1.63B |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.73B | $3.80B |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.14B | $1.66B |
| Teladoc Health, Inc. (TDOC)vs › | $1.00B | $1.26B |
| Beam Therapeutics Inc. (BEAM)vs › | $2.51B | $2.54B |
| TransMedics Group, Inc. (TMDX)vs › | $2.74B | $3.13B |
| NeoGenomics, Inc. (NEO)vs › | $472.39M | $775.22M |
| NRC Health (NRC)vs › | $459.30M | $546.00M |
| Shoulder Innovations, Inc. (SI)vs › | $397.55M | $387.94M |
| PDS Biotechnology Corporation (PDSB)vs › | $41.03M | $39.80M |
Market Cap
$1.72B
Total Debt
$66.85M
Cash
$155.46M
Enterprise Value
$1.63B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
